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Background: To evaluate different types of acupuncture treatment for migraine in China from the perspective of
health economics, particularly the comparison between treatment of specific acupoints in Shaoyang meridians and
penetrating sham acupoints treatment.
Methods: Data were obtained from a multicenter, randomized controlled trial of acupuncture treatment in patients
with migraine. Four-hundred eighty migraineurs were randomly assigned to 3 arms of treatment with genuine
acupoints and 1 arm of penetrating sham acupoints. The primary outcome measurement was the cost-effectiveness
ratio (C/E), expressed as cost per 1 day reduction of headache days from baseline to week 16. Cost-comparison
analyses, differences in the migraine-specific quality of life questionnaire (MSQ), and the incremental cost-
effectiveness ratio were taken as secondary outcome measurements. In addition, a sensitivity analysis was
conducted.
Results: The total cost per patient was ¥1273.2 (95% CI 1171.3-1375.1) in the Shaoyang specific group, ¥1427.7
(95% CI 1311.8-1543.6) in the Shaoyang non-specific group, ¥1490.8 (95% CI 1327.1-1654.6) in the Yangming specific
group, and ¥1470.1 (95% CI 1358.8-1581.3) in the sham acupuncture group. The reduced days with migraine were
3.972 ± 2.7, 3.555 ± 2.8, 3.793 ± 3.6, and 2.155 ± 3.7 in these 4 groups (P< 0.05 for each genuine acupoints group vs
the sham group), respectively, at week 16. The C/Es of the 4 groups were 320.5, 401.6, 393.1, and 682.2, respectively.
Results of the sensitivity analysis were consistent with that of the cost-effectiveness analysis. The Shaoyang specific
group significantly improved in all 3 MSQ domains compared with the sham acupuncture group.
Conclusions: Treatment of specific acupoints in Shaoyang meridians is more cost-effective than that of non-
acupoints, representing a dramatic improvement in the quality of life of people with migraine and a significant
reduction in cost. Compared with the other 3 groups, Shaoyang-specific acupuncture is a relatively cost-effective
treatment for migraine prophylaxis in China.
Trial registration: Clinical Trials.gov NCT00599586
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Migraine is characterized by attacks of moderate to se-
vere pulsating and mostly unilateral headache, lasting
from 4 to 72 hours, with associated symptoms of nausea,
vomiting, and/or photophobia or phonophobia [1].
According to the results of a number of studies, a 1-year
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reproduction in any medium, provided the orhaving higher rates than males [2,3]. Migraine mostly
impacts individuals aged 25 to 55 years, the years of
strong productivity, thus resulting in a loss of productiv-
ity and posing a tremendous economic burden to society
[4]. A US study in 1999 showed that the monetary loss
associated with lost productivity due to headache attacks
was estimated to be in the range of $US64-150 million
dollars [5].
Acupuncture, a form of traditional Chinese medicine
(TCM) therapy, has been gradually accepted in the Westtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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has the advantage of having fewer side effects than
drugs. Acupuncture was reported as a cost-effective
treatment for patients with primary headache, improving
health-related quality of life [6,7]. However, whether
genuine acupuncture in China is more cost-effective
than penetrating sham acupuncture is still unknown.
Therefore, we performed a cost-effectiveness analysis
based on data from a randomized controlled trial to in-
vestigate the cost-effectiveness of different acupuncture
treatments, particularly that of specific acupoints in




This study was a health economic evaluation embedded
in a multicenter, randomized controlled trial, which was
part of a clinical research project supported by China’s
National Key Basic Research Program. The trial protocol
and the type of informed consent form were followed
the principles of the Declaration of Helsinki and pro-
vided and approved by local institutional review boards
(including the Ethics Committee of first affiliated Hos-
pital of Chengdu University of TCM, the Ethics Com-
mittee of First affiliated Hospital of Hunan University of
TCM, the Ethics Committee of TCM Hospital of Wuhan
City, the Ethics Committee of teaching Hospital of
Ningxia Medicine University). All patients gave written
informed consent.
Participants aged 18–65 years who met the diagnosis
of migraine for ≥ 1 year with at least 2 migraine attacks
per month during the last 3 months before
randomization were eligible. This study was carried out
from April 2008 to December 2009 in China. All partici-
pating acupuncturists were required to be qualified with
special training for this trial.
Participants were randomly assigned by a central
randomization system into 4 treatment groups using:
specific acupoints in Shaoyang meridians (group A),
non-specific acupoints in Shaoyang meridians (group B),
specific acupoints in Yangming meridians (group C), and
non-acupoints in all the limbs (group D). Participants
received 20 acupuncture sessions with disposable acu-
puncture needles over a period of 4 weeks. Outcome
measurements were assessed at week 0, 4, 8, and 16.
Each follow-up carefully assessed the average state of the
4 weeks prior to any given time point. Further details
about the design and main clinical outcomes of this
study have been published elsewhere [8,9].
Cost components
Because this study was carried out in 4 cities Chengdu,
Changsha, Wuhan, and Yinchuan in China. We measuredcosts in Chinese Yuan (CNY, ¥, 1 USD=6.82 CNY on
31th, December, 2009) [10-13]. Costs were categorized as
direct and indirect costs. Direct costs comprised acupunc-
ture fees, drug costs, and examination charges. The stan-
dard costs of acupuncture treatment per session were 36,
40, 40, 20 (CNY, ¥) in Chengdu, Changsha, Wuhan, and
Yinchuan, respectively. Drug costs included all acute and
prophylactic medications taken by participants during the
treatment and 3-month follow-up. Examination charges
involved routine tests for blood, urine and stool, liver and
kidney function, an electrocardiograph at baseline, and a
transcranial Doppler ultrasound (TCD) examination at
baseline and week 4. Not all participants received all the
above tests. For example, some migraineurs refused to
have a routine stool test, or some missed the second TCD
examination at week 4. We therefore calculated exami-
nation charges separately. Indirect costs, which from a
societal view arose owing to work incapacity for migraine
episodes during the study, were evaluated in terms of days
of sick-leave from work or other activities like housework.
Indirect costs were more difficult to estimate accurately
because we did not have access to individuals' salary infor-
mation. We roughly estimated average daily wages using
data from statistical yearbooks based on participants’
occupations and locations. Transportation costs that parti-
cipants incurred to receive acupuncture treatments were
not taken into account as they were not recorded. As the
trial period lasted only 16 weeks, discounting rates were
not required.
Primary outcome measurement
The main outcome was the cost-effectiveness ratio (C/E),
expressed as the cost per 1 day reduction of headache
days. We evaluated effectiveness in terms of differences
in migraine days between baseline and week 16 after
randomization. This provided a more informative and
less subjective approach than use of other outcomes such
as migraine intensity [14].
Secondary outcome measurements
Secondary outcome measurements included costs, scores
on the migraine-specific quality of life questionnaire
(MSQ V2.1), and the incremental cost-effectiveness ratio
(ICER). In addition, a sensitivity analysis was also
performed.
MSQ data were acquired at baseline, 4, 8, and 16 weeks
by using the Last Observation Carried Forward (LOCF)
method. The endpoint was defined as the last available
post-baseline observation. The 14-item MSQ assessed
the degree of migraineurs’ quality of life over the past
4 weeks in 3 domains: Role Restrictive (RR), Role Pre-
ventive (RP), and Emotional Function (EF) [15]. All 3
MSQ dimensions are scored from 0 to 100, with higher
scores indicating better states [16]. The reliability and
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studies [17].Statistical analysis
For sociodemographic baseline characteristics, analysis
of variance was used for continuous variables and the
chi-squared test for categorical variables. Moreover,
analysis of covariance was used for the primary outcome
measurement adjusted for center and baseline values. As
cost data were not normally distributed, we used the
Kruskal-Wallis test. Two-sided tests were applied for all
data, and a P value< 0.05 was considered statistically
significant. All analyses were done with SAS statistical
software (version 9.2, SAS Institute Inc., Cary, NC, USA)
and SPSS statistical software (version 13.0, SPSS Inc.,
Chicago, IL, USA).Results and discussion
Baseline characteristics
A total of 480 participants enrolled, but 41 dropped out
of the study for the following reasons: 3 because of false
inclusion, 1 because of data loss of the primary outcome,
15 because of unsatisfactory treatments (group A, 3;
group B, 4; group C, 4; group D, 4), 17 because of no
specific reason (group A, 7; group B, 5; group C, 3;
group D, 2), and 5 because of other reasons, such as
work issues (group A, 3; group B, 0; group C, 0; group
D, 2). In all, 439 participants received at least 12 acu-
puncture treatment sessions and 3 months’ follow-up,
which constituted the cost-effectiveness analysis sample.
Groups were comparable in most baseline characteristics
with the exception of days of lost work owing to mi-
graine attacks in the last 4 weeks before randomization.
Thus, a difference was also found in the costs of sick
days due to migraine attacks before randomization




group (n = 11
Age 37.1 (11.7) 36.2 (12
Women 100 (82.6%) 99 (83
Migraine type
With aura 18 (14.9%) 14 (11
Without aura 103 (85.1%) 105 (88
Duration of illness (months) 119.8 (115.3) 91.8 (78
Migraine days last month** 6.3 (5.1) 5.6 (3.2
number of lost work days due to 3.0(3.2) 3.9(3.0
migraine attacks last month**
ITT = Intention-to-treat, defined as the number of patients who received at least on
Standard Deviation; * Significant difference, P< 0.05. **The average state of 4 weekCost analysis
Table 2 shows that the wages per lost workday were
comparable among the study groups. We found no sig-
nificant intergroup differences among all items in the
direct costs category (P> 0.05). However, we did find
significant differences for indirect costs (P< 0.05). There
was no difference for charge by week 4; however, we
found a statistically significant difference for charge by
weeks 8 and 16. The Shaoyang specific group had sig-
nificantly lower indirect and overall costs compared with
the other 3 groups (Table 2).
Quality of life
From a health economic perspective, costs as well as
quality of life should be taken into account. Therefore,
we used MSQ scores to evaluate quality of life. As 37
participants dropped out during treatment and follow-
up (group A: 13, group B: 9, group C: 7, group D: 8), the
LOCF method was used for this missing information.
Detailed MSQ data can be found in our main clinical
publication [9]. Figure 1 shows mean scores at baseline
and weeks 4, 8, and 16 for the RR, RP, and EF domains.
After acupuncture treatment for all 4 groups, scores in
all 3 MSQ domains increased and reached their peaks
by the endpoint, except for the RR domain in the sham
acupuncture group, whose peak occurred at week 8. Sig-
nificant differences (P< 0.05) were found in all 3
domains at weeks 4, 8, and 16 for the Shaoyang specific
group compared with the sham acupuncture group.
Cost-effectiveness analysis
The number of reduced days with migraine was
3.972± 2.7, 3.555 ± 2.8, 3.793 ± 3.6, and 2.155± 3.7 for the
Shaoyang-specific group, Shaoyang non-specific group,
Yangming specific group, and sham acupuncture group,
respectively, at week 16 (P< 0.05 for each of the genuine
acupoints group vs the non-acupoints group). Groups





group (n = 118)
P values*
.4) 36.8 (13.0) 37.5 (12.1) 0.870
.2%) 92 (78.0%) 103 (87.3%) 0.306
0.635
.8%) 12 (10.2%) 12 (10.2%)
.2%) 106 (89.8%) 106 (89.8%)
.6) 104.0 (100.7) 102.0 (93.4) 0.172
) 6.1 (4.6) 5.5 (4.0) 0.387
) 3.9 (3.7) 2.9(2.7) 0.014*
e acupuncture treatment session. Data are number (%) or mean (SD).SD,
s before treatment.
Table 2 Cost-comparison analyses in ¥
Cost components Shaoyang specific
group (n = 108)
mean[95% CI]
Shaoyang non-specific
group (n = 110)
mean [95% CI]
Yangming specific
group (n = 111)
mean [95% CI]
Sham acupuncture
group (n = 110)
mean [95% CI]
P values*
Wage per lost day 78.9[70.7;86.9] 78.3[69.2;87.3] 76.0[67.6;84.4] 81.7[73.5;89.8] 0.673




Examinations 349.3[338.7;359.8] 344.7[336.7;352.6] 337.1[326.2;348.0] 343.4[332.7;354.0] 0.358
Acupuncture 709.0[659.6;758.5] 685.7[647.5;723.9] 721.0[678.2;763.8] 690.1[642.6;737.5] 1.00
Drug fees 2.6[1.27;3.85] 2.7[1.39;3.93] 3.7[0.64;6.78] 5.7[1.54;9.85] 0.578
Total cost 1060.9[1005.4;1116.3] 1033.0[990.7;1075.3] 1061.8[1012.3;1111.3] 1039.1[985.7;1092.6] 0.717
Indirect costs
During treatment 109.3[68.8;149.7] 188.0 [123.9;252.2] 183.3[122.0;244.9] 153.8[115.7;191.9] 0.005{*
Weeks 5-8 57.6[31.01;84.17] 129.0[87.71;170.2] 130.6[79.2;182.1] 128.6[90.22;167.0] <0.001{*
Weeks 13-16 45.5[24.0;67.0] 77.7[56.0;99.4] 115.1 [60.3;167.0] 148.6[103,5;193.6] <0.001{*
Total cost 212.3[132.3;292.3] 394.7[289.3;500.1] 429.0[272.6;585.5] 430.9[327.7;534.1] <0.001{*
Charge by week 4 1170.1[1097.6;1242.6] 1221.1[1142.5;1299.8] 1245.1[1167.4;1322.8] 1192.9[1128.4;1257.3] 0.231
Charge by week 8 1227.7[1137.9;1317.5] 1350.0[1242.1;1457.9] 1375.7[1257.6;1493.8] 1321.5[1240.9;1402.o] 0.029{*
Overall cost 1273.2[1171.3;1375.1] 1427.7[1311.8;1543.6] 1490.8[1327.1;1654.6] 1470.1[1358.8;1581.3] 0.004{*
{P values based on the Kruskal–Wallis test;* Significant difference, P< 0.05.
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puncture group, with the best improvement being in the
Shaoyang specific group. Based on the cost data and the
changes of migraine days from baseline, we performed a
cost-effectiveness analysis. The Shaoyang-specific group
had a relatively lower C/E than that of the other 3 groups
at week 16, and the sham acupuncture group had the
highest. Therefore, the negative ICER for treatments in
other meridians and non-acupoints indicated that those
treatments have a higher expected cost than treatment
using Shaoyang specific acupoints (Table 3).Sensitivity analyses
Sensitivity analyses are used to test different assump-
tions and estimate the influence due to different cost
changes. In addition to performing a sensitivity analysis,
to improve the external validity of our health economic
results we varied acupuncture fees within realistic
ranges, taking it as the most important study parameter.
During the course of implementing acupuncture treat-
ment, supposing the price fluctuates by 10%-20%
according to different hospitals, we conducted a sensitiv-
ity analysis. As indicated in Figure 2, the 4 lines show
the C/E fluctuation corresponding to the changes of acu-
puncture fees. The Shaoyang specific group was always
lower than the other 3 groups as acupuncture fees were
allowed to drift up and down by 10%-20%. We couldestimate that the results of the cost-effectiveness analysis
appeared steady to cost changes.Discussion
Among the groups studied, we found that acupuncture
using specific acupoints in Shaoyang meridians was the
most efficacious and least costly. The sensitivity analysis
was consistent with the cost-effectiveness analysis. This
result met what we found in the clinical trial whereby
acupoints were more efficacious than non-acupoints at
managing migraine. The 4 groups showed similar
improvements in weeks 5 to 8; however, there was a sig-
nificant reduction of migraine days during weeks 13–16
[9]. According to TCM theory, genuine acupoints treat-
ment is more effective than non-acupoints treatment
based on specific physiological effects related to meri-
dians and collections of meridian Qi. The findings of this
study, from the perspective of health economics, support
the use of Shaoyang specific acupoint treatment for mi-
graine compared with the other acupuncture treatments
studied.
MSQ outcomes were better for participants in the
Shaoyang specific group compared with the other
groups. Based on the evaluation of MSQ scores, the
Shaoyang specific group participants showed significant
and sustained improvement in daily activities and well-




































































































Week0 Week4 Week8 Week16
Figure 1 MSQ mean scores at various time points. * Shaoyang-specific group vs. sham acupuncture group, P< 0.05. † Shaoyang-non-specific
group vs. sham acupuncture group, P< 0.05. { Yangming-specific group vs. sham acupuncture group, P< 0.05.
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baseline was probably due to sample size. However, in-
direct costs measured at the following 3 time points
probably were not influenced by the small sample size
because penetrating sham acupuncture treatment, hav-
ing the lowest indirect costs, was superior to the 3 genu-
ine acupuncture groups at the beginning.Table 3 Cost-effectiveness analysis
Week 16 C
(Total cost ¥) (r
Shaoyang specific group
Shaoyang specific group 1273.18
Shaoyang non-specific group 1427.70
Yangming specific group 1490.84
Sham acupuncture group 1470.06
a Numbers in parentheses are negative ICER values.The study has the following limitations. First, the
study design did not have routine drug therapy as a
control group. The clinical trial was designed to investi-
gate the efficacy of acupuncture (verum acupuncture
and penetrating sham acupuncture), so usual care was
not involved. Second, cost-utility analysis was not pos-
sible to use here. The disease-specific MSQ wereE




3.793 393.1 (1216.0) a
2.155 682.2 (108.4) a
Figure 2 Sensitivity analyses. The cost-effectiveness ratio varied by acupuncture fees, which were allowed to drift up and down by 10%-20%.
C = Total cost (CNY).
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(SF-36), which is a generic scale not necessarily affected
by a specific disease. We could not obtain quality-
adjusted life years(QALY). The value of our analysis
was limited to a single measure, which could not be
used to compare situations with different benefits. A
follow-up visit at week 12 was not initially included in
the study design for collecting data from week 9 to
week 12. Therefore, we were not able to estimate costs
due to lost productivity and drug fees paid by partici-
pants during weeks 9–12.
Acupuncture, with its unique feature and advantages,
has been widely applied in the treatment of many neuro-
logical disorders; however, its benefits still lack strong
evidence from the perspective of health economics.
Health economics deals with optimizing the allocation
of healthcare resources. Because of the limited health
resources in China, more health economics evaluations
are needed to provide evidence for optimal allocation of
healthcare resources. To our knowledge, this is the first
economic evaluation of acupuncture treatment for mi-
graine in China.Conclusions
Our study showed that treatment using specific acu-
points in the meridians of Shaoyang is more cost-
effective than that using non-acupoints, representing a
dramatic improvement in the quality of life for migrai-
neurs and a significant reduction in cost. Compared with
the other 3 groups, the method of selecting specific acu-
points in the meridians of Shaoyang is a relatively cost-
effective treatment for migraine prophylaxis.Competing interests
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